Quick answers
- What is Edurant Ped?
- Edurant Ped is a brand name of Rilpivirine hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Edurant Ped product in 1 strength and form.
- Who makes Edurant Ped?
- Janssen Prods holds the FDA application for Edurant Ped (NDA219016, approved March 15, 2024).
- Is there a generic or store brand of Edurant Ped?
- Other products of Rilpivirine hydrochloride are listed with the FDA, but none in exactly the same strength and form as a Edurant Ped product.
- Has Edurant Ped been recalled?
- No recall linked to Edurant Ped products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Edurant Ped is
Each Edurant Ped product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Rilpivirine hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| rilpivirine hydrochloride 2.5 mg tablet, for suspension (oral) | Edurant Ped | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Rilpivirine hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA219016 | Janssen Prods | March 15, 2024 | 1 |
Companies that list Edurant Ped
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Edurant Ped products.
- Janssen Products, LP1 product
Recalls
No recall linked to Edurant Ped products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.